“…Cells were treated with the following reagents: ethylene glycol tetraacetic acid (EGTA), SKF96365, mibefradil, nimodipine, D(−)-2-amino-5-phosphonopentanoic acid (D-APV), 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), cobalt chloride (CoCl 2 ), 1-oleoyl-2-acetyl-sn-glycerol (OAG), thapsigargin, 2-aminoethyl diphenylborinate (2-APB), MG132 and dimethyloxalylglycine N-(methoxyoxoacetyl)-glycine methyl ester (DMOG), all purchased from Sigma; U73122 from Calbiochem; suramin from Santa Cruz Biotechnology; pazopanib, canertinib dihydrochloride and BMS-754807 from MedChem Express; and K252a from Merck. The 3-nitrocoumarin and 7-OH-3-nitrocoumarin were gifts from Renata Tisi and Enzo Martegani (Milano-Bicocca University, Milan, Italy) (He et al, 2012). Recombinant human IGF-1 was from PeproTech.…”